The medication starts the journey
This may support more stable appetite suppression and energy balance effects, though weight loss outcomes depend on multiple factors beyond site selection alone
doi:10.1038/emm.2007.88 Rothstein JD, Dykes-Hoberg M, Pardo CA, Bristol LA, Jin L, Kuncl RW, Kanai Y, Hediger MA et al (1996) Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate
The primary endpoint, assessed at 6 months and at 1 year as a secondary endpoint, is Patient-Reported OutcomeSide Effects (PROS)a composite measure of dysphagia, odynophagia, inability to belch/vomit, and gas-bloating
It reduced homocysteine levels
Episode 19: Jennie - Obesity Is Not a Moral Failure 53:17|Season 1, Ep